Stay updated on Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.

Latest updates to the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check50 days agoChange DetectedThe website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, which may impact performance and availability.SummaryDifference0.6%
- Check64 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check79 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check100 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check107 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the 'Contacts and Locations' section in the study record.SummaryDifference1%
Stay in the know with updates to Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.